Biotech by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

BioNTech has the lowest figure of the 24 biotech ranked by short interest, at 0.91%, followed by Gilead Sciences (1.72%) and argenx (2.25%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
BioNTech0.91%
Median
9.33%
Combined market value
PLN 3.37T
Countries
5

Market values as of .

Biotech by short interest
#CompanyShort interest % ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BioNTechBNTX · Health Care0.91%PLN 83.7BPLN 337.78 1.01% down 16% down Germany
2Gilead SciencesGILD · Health Care1.72%PLN 840.5BPLN 677.62 1.02% down 33% up United States
3argenxARGX · Health Care2.25%PLN 239.2BPLN 3,803.82 0.16% down 4% up Belgium
4AmgenAMGN · Health Care2.33%PLN 971.7BPLN 1,796.39 2.44% down 34% up United States
5QiagenQGEN · Health Care3.10%PLN 41.2BPLN 199.31 0.37% down 12% up Netherlands
6BiogenBIIB · Health Care3.69%PLN 148.3BPLN 1,003.06 0.53% down 49% up United States
7Bio-TechneTECH · Health Care4.90%PLN 45.9BPLN 292.43 0.13% up 26% up United States
8Neurocrine BiosciencesNBIX · Health Care5.83%PLN 66.1BPLN 653.05 2.12% down 20% up United States
9Revolution MedicinesRVMD · Health Care6.05%PLN 139.2BPLN 643.38 1.65% down 131% up United States
10Adaptive BiotechnologiesADPT · Health Care7.09%PLN 18.3BPLN 113.03 1.33% down 88% up United States
11ModernaMRNA · Health Care8.20%PLN 326.5BPLN 806.98 2.96% down 755% up United States
12ImmunovantIMVT · Health Care8.96%PLN 28BPLN 135.25 1.28% up 43% up United States
13VaxcytePCVX · Health Care9.70%PLN 37.5BPLN 236.90 0.82% down 22% up United States
14Kymera TherapeuticsKYMR · Health Care9.84%PLN 41.4BPLN 485.35 0.67% down 87% up United States
15Krystal BiotechKRYS · Health Care10.3%PLN 36.8BPLN 1,240.77 3.35% up 46% up United States
16CG OncologyCGON · Health Care10.3%PLN 28.6BPLN 320.04 0.82% up 85% up United States
17ExelixisEXEL · Health Care10.5%PLN 67.6BPLN 277.13 0.61% up 63% up United States
18RepligenRGEN · Health Care11.0%PLN 43.8BPLN 685.88 5.17% up 5% up United States
19ImmunityBioIBRX · Health Care11.9%PLN 28.2BPLN 26.54 5.43% up 193% up United States
20Halozyme TherapeuticsHALO · Health Care12.0%PLN 44.4BPLN 389.79 1.01% up 37% up United States
21Kodiak SciencesKOD · Health Care12.4%PLN 25.3BPLN 386.91 0.60% down 396% up United States
22Twist BioscienceTWST · Health Care14.4%PLN 31.5BPLN 462.23 2.63% up 340% up United States
23CRISPR TherapeuticsCRSP · Health Care17.7%PLN 16.1BPLN 166.19 2.94% up 21% down Switzerland
24Scholar Rock HoldingSRRK · Health Care19.2%PLN 23.2BPLN 190.32 4.99% up 14% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0211 PLN).

Questions and answers

Which biotech have the lowest short interest?

BioNTech (0.91%), Gilead Sciences (1.72%) and argenx (2.25%) have the lowest short interest of the 24 biotech ranked here as of the 30 Oct 2026 settlement date.

How many biotech are in this ranking?

24 are ranked by short interest.

What are these biotech worth together?

The 24 biotech ranked by short interest have a combined market value of PLN 3.37T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.